Teon Therapeutics

Teon Therapeutics is developing a combination of single-target small molecules that affect metabolic signaling pathways in the tumor microenvironment. Teon Therapeutics' pipeline consists of first-class drug candidates whose targets influence both immune cells and cancer cells.